Phase 4 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with osteoarthritis (wear-and-tear joint disease) in one or both hips or knees, confirmed by an X-ray showing a certain level of joint damage, where the condition has been causing pain for at least 3 months.
- People who experience pain when walking that rates at least 4 out of 10 in intensity.
- People who currently do fewer than 3 walks of at least 20 minutes (or 1,000 steps) per week.
- People who are able to understand the study instructions and complete the questionnaires involved.
Who may not be able to join:
- People who are pregnant or breastfeeding.
- People who are under legal guardianship or court-ordered protection.
- People who weigh less than 40 kg or are classified as underweight.
- People who weigh more than 120 kg or are classified as obese.
- People who are unable to walk at all, or who cannot walk without the use of major support devices (note: walking sticks, crutches, braces, and knee supports are allowed).
- People whose osteoarthritis is caused by another underlying condition, such as rheumatoid arthritis, a joint infection, gout, or certain metabolic disorders, rather than general wear and tear.
- People who have another bone disease affecting the whole body, such as Paget's disease.
- People who have another significant source of pain unrelated to osteoarthritis, such as nerve pain or fibromyalgia.
- People who have recently had a procedure — such as surgery, keyhole joint surgery, or a joint injection — that would be expected to reduce their osteoarthritis pain during the study period.
- People who have a similar joint procedure planned during the study period.
- People who have recently started a new pain-relief medication, including steroid tablets or injections.
- People who have plans to start a pain-relief program during the study period, such as physiotherapy or cognitive behavioural therapy.
- People who have major surgery planned during the study period.
- People who currently have cancer.
- People whose immune system is suppressed (for example, due to medication or illness).
- People who have an autoimmune disease.
- People who are currently using anti-inflammatory medications (NSAIDs) applied to the skin or taken by mouth.
- People who regularly take strong opioid pain medications.
- People who are currently on insulin therapy.
- People for whom anti-inflammatory medications (NSAIDs) or paracetamol (acetaminophen) are medically unsuitable, according to French medicines authority guidelines.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 04 73 75 11 95
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Success
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.